Bevacizumab in aggressive pituitary adenomas–experience with 3 patients

K Osterhage, R Rotermund, M Droste… - Experimental and …, 2021 - thieme-connect.com
Objective To investigate bevacizumab as alternative treatment of aggressive pituitary
adenomas after exhaustion of standard therapies. Design and Methods Retrospectively, 3 …
被引用次数：22 相关文章

Bevacizumab in Aggressive Pituitary Adenomas-Experience with 3 Patients.

K Osterhage, R Rotermund, M Droste… - … & Diabetes: Official …, 2020 - europepmc.org
Bevacizumab in Aggressive Pituitary Adenomas - Experience with 3 Patients. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …

Bevacizumab in Aggressive Pituitary Adenomas–Experience with 3 Patients

K Osterhage, R Rotermund, M Droste… - Experimental and …, 2021 - thieme-connect.com
Objective To investigate bevacizumab as alternative treatment of aggressive pituitary
adenomas after exhaustion of standard therapies. Design and Methods Retrospectively, 3 …

Bevacizumab in Aggressive Pituitary Adenomas-Experience with 3 Patients

K Osterhage, R Rotermund… - … & diabetes: official …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective To investigate bevacizumab as alternative treatment of aggressive pituitary
adenomas after exhaustion of standard therapies. Design and methods Retrospectively, 3 …